Seaport Research raised the firm’s price target on Hims & Hers to $32 from $28 and keeps a Buy rating on the shares. The company increases its price target on the stock following “strong” Q3 results and increased guidance, the analyst tells investors. While the firm expects continued investor uncertainty around the durability of the company’s weight loss offerings, Seaport is optimistic that its multi-pronged approach will demonstrate “solid” long-term growth.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hims & Hers price target raised to $21 from $18 at Piper Sandler
- Hims & Hers price target raised to $28 from $24 at Canaccord
- Hims & Hers Health Reports Strong Q3 2024 Growth
- Closing Bell Movers: Palantir jumps 13% after results
- Hims & Hers to stop reporting on orders, average order value after 2024